Getting Imbruvica (Ibrutinib) Covered by Aetna CVS Health in Virginia: Forms, Appeals, and Step Therapy Rights
Quick Answer: Your Path to Approval
Imbruvica (ibrutinib) requires prior authorization from Aetna CVS Health but no step therapy for CLL/SLL. In Virginia, you have strong appeal rights: 72-hour step therapy override decisions, 180 days to appeal denials, and external review through the State Corporation Commission using Form 216-A.